1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide

C149H286F3N13O26 — CID 163628736

IUPAC1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide
SMILESCC(=O)C(C)C.CC(=O)CC(C)C.CC(C)C(=O)CC(C)(C)C.CC(C)C(=O)N(C)C.CC(C)C(=O)N1CC(C)(C)C1.CC(C)C(=O)N1CC(O)C1.CC(C)C(=O)N1CCC(C)(C(F)(F)F)CC1.CC(C)C(=O)N1CCC(C)(O)CC1.CC(C)C(=O)N1CCC(O)CC1.CC(C)C(=O)N1CCC1.CC(C)C(=O)N1CCC2(CCC2)CC1.CC(C)C(=O)N1CCOCC1.CC(C)C(=O)NC1COC1.CC(C)C(=O)NCC(C)(C)O.CC(C)C(=O)NCC1COC1.CC(C)CC(=O)C(C)C.CCC(=O)CC(C)C.CCCC(=O)C(C)C.CNC(=O)C(C)C
InChIInChI=1S/C12H21NO.C11H18F3NO.C10H19NO2.C9H17NO2.C9H17NO.C9H18O.2C8H15NO2.C8H17NO2.C8H16O.2C7H13NO2.C7H13NO.2C7H14O.C6H13NO.C6H12O.C5H11NO.C5H10O/c1-10(2)11(14)13-8-6-12(7-9-13)4-3-5-12;1-8(2)9(16)15-6-4-10(3,5-7-15)11(12,13)14;1-8(2)9(12)11-6-4-10(3,13)5-7-11;1-7(2)9(12)10-5-3-8(11)4-6-10;1-7(2)8(11)10-5-9(3,4)6-10;1-7(2)8(10)6-9(3,4)5;1-6(2)8(10)9-3-7-4-11-5-7;1-7(2)8(10)9-3-5-11-6-4-9;1-6(2)7(10)9-5-8(3,4)11;1-6(2)5-8(9)7(3)4;1-5(2)7(9)8-6-3-10-4-6;1-5(2)7(10)8-3-6(9)4-8;1-6(2)7(9)8-4-3-5-8;1-4-7(8)5-6(2)3;1-4-5-7(8)6(2)3;1-5(2)6(8)7(3)4;1-5(2)4-6(3)7;1-4(2)5(7)6-3;1-4(2)5(3)6/h10H,3-9H2,1-2H3;8H,4-7H2,1-3H3;8,13H,4-7H2,1-3H3;7-8,11H,3-6H2,1-2H3;7H,5-6H2,1-4H3;7H,6H2,1-5H3;6-7H,3-5H2,1-2H3,(H,9,10);7H,3-6H2,1-2H3;6,11H,5H2,1-4H3,(H,9,10);6-7H,5H2,1-4H3;5-6H,3-4H2,1-2H3,(H,8,9);5-6,9H,3-4H2,1-2H3;6H,3-5H2,1-2H3;2*6H,4-5H2,1-3H3;5H,1-4H3;5H,4H2,1-3H3;4H,1-3H3,(H,6,7);4H,1-3H3
InChIKeyHUFYNRPJVJDXMU-UHFFFAOYSA-N
MW2732.99 g/mol
LogP23.63
Rot. Bonds32

About 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide

1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide (PubChem CID 163628736) has the molecular formula C149H286F3N13O26 and a molecular weight of 2732.99 g/mol. Its IUPAC name is 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide.

Molecular Properties

Compound Name1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide
PubChem CID163628736
Molecular FormulaC149H286F3N13O26
Molecular Weight2732.99 g/mol
Exact Mass2731.14
IUPAC Name1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide
SMILESCC(=O)C(C)C.CC(=O)CC(C)C.CC(C)C(=O)CC(C)(C)C.CC(C)C(=O)N(C)C.CC(C)C(=O)N1CC(C)(C)C1.CC(C)C(=O)N1CC(O)C1.CC(C)C(=O)N1CCC(C)(C(F)(F)F)CC1.CC(C)C(=O)N1CCC(C)(O)CC1.CC(C)C(=O)N1CCC(O)CC1.CC(C)C(=O)N1CCC1.CC(C)C(=O)N1CCC2(CCC2)CC1.CC(C)C(=O)N1CCOCC1.CC(C)C(=O)NC1COC1.CC(C)C(=O)NCC(C)(C)O.CC(C)C(=O)NCC1COC1.CC(C)CC(=O)C(C)C.CCC(=O)CC(C)C.CCCC(=O)C(C)C.CNC(=O)C(C)C
InChIInChI=1S/C12H21NO.C11H18F3NO.C10H19NO2.C9H17NO2.C9H17NO.C9H18O.2C8H15NO2.C8H17NO2.C8H16O.2C7H13NO2.C7H13NO.2C7H14O.C6H13NO.C6H12O.C5H11NO.C5H10O/c1-10(2)11(14)13-8-6-12(7-9-13)4-3-5-12;1-8(2)9(16)15-6-4-10(3,5-7-15)11(12,13)14;1-8(2)9(12)11-6-4-10(3,13)5-7-11;1-7(2)9(12)10-5-3-8(11)4-6-10;1-7(2)8(11)10-5-9(3,4)6-10;1-7(2)8(10)6-9(3,4)5;1-6(2)8(10)9-3-7-4-11-5-7;1-7(2)8(10)9-3-5-11-6-4-9;1-6(2)7(10)9-5-8(3,4)11;1-6(2)5-8(9)7(3)4;1-5(2)7(9)8-6-3-10-4-6;1-5(2)7(10)8-3-6(9)4-8;1-6(2)7(9)8-4-3-5-8;1-4-7(8)5-6(2)3;1-4-5-7(8)6(2)3;1-5(2)6(8)7(3)4;1-5(2)4-6(3)7;1-4(2)5(7)6-3;1-4(2)5(3)6/h10H,3-9H2,1-2H3;8H,4-7H2,1-3H3;8,13H,4-7H2,1-3H3;7-8,11H,3-6H2,1-2H3;7H,5-6H2,1-4H3;7H,6H2,1-5H3;6-7H,3-5H2,1-2H3,(H,9,10);7H,3-6H2,1-2H3;6,11H,5H2,1-4H3,(H,9,10);6-7H,5H2,1-4H3;5-6H,3-4H2,1-2H3,(H,8,9);5-6,9H,3-4H2,1-2H3;6H,3-5H2,1-2H3;2*6H,4-5H2,1-3H3;5H,1-4H3;5H,4H2,1-3H3;4H,1-3H3,(H,6,7);4H,1-3H3
InChIKeyHUFYNRPJVJDXMU-UHFFFAOYSA-N
XLogP23.63
TPSA510.22 Ų
H-Bond Donors8
H-Bond Acceptors26
Rotatable Bonds32
Heavy Atoms191
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002732.99
LogP ≤ 523.63
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1026

Analyze 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide?
The IUPAC name of 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide (CID 163628736) is 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide.
What is the SMILES notation for 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide?
The canonical SMILES for 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide is CC(=O)C(C)C.CC(=O)CC(C)C.CC(C)C(=O)CC(C)(C)C.CC(C)C(=O)N(C)C.CC(C)C(=O)N1CC(C)(C)C1.CC(C)C(=O)N1CC(O)C1.CC(C)C(=O)N1CCC(C)(C(F)(F)F)CC1.CC(C)C(=O)N1CCC(C)(O)CC1.CC(C)C(=O)N1CCC(O)CC1.CC(C)C(=O)N1CCC1.CC(C)C(=O)N1CCC2(CCC2)CC1.CC(C)C(=O)N1CCOCC1.CC(C)C(=O)NC1COC1.CC(C)C(=O)NCC(C)(C)O.CC(C)C(=O)NCC1COC1.CC(C)CC(=O)C(C)C.CCC(=O)CC(C)C.CCCC(=O)C(C)C.CNC(=O)C(C)C.
What is the InChIKey of 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide?
The InChIKey is HUFYNRPJVJDXMU-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H21NO.C11H18F3NO.C10H19NO2.C9H17NO2.C9H17NO.C9H18O.2C8H15NO2.C8H17NO2.C8H16O.2C7H13NO2.C7H13NO.2C7H14O.C6H13NO.C6H12O.C5H11NO.C5H10O/c1-10(2)11(14)13-8-6-12(7-9-13)4-3-5-12;1-8(2)9(16)15-6-4-10(3,5-7-15)11(12,13)14;1-8(2)9(12)11-6-4-10(3,13)5-7-11;1-7(2)9(12)10-5-3-8(11)4-6-10;1-7(2)8(11)10-5-9(3,4)6-10;1-7(2)8(10)6-9(3,4)5;1-6(2)8(10)9-3-7-4-11-5-7;1-7(2)8(10)9-3-5-11-6-4-9;1-6(2)7(10)9-5-8(3,4)11;1-6(2)5-8(9)7(3)4;1-5(2)7(9)8-6-3-10-4-6;1-5(2)7(10)8-3-6(9)4-8;1-6(2)7(9)8-4-3-5-8;1-4-7(8)5-6(2)3;1-4-5-7(8)6(2)3;1-5(2)6(8)7(3)4;1-5(2)4-6(3)7;1-4(2)5(7)6-3;1-4(2)5(3)6/h10H,3-9H2,1-2H3;8H,4-7H2,1-3H3;8,13H,4-7H2,1-3H3;7-8,11H,3-6H2,1-2H3;7H,5-6H2,1-4H3;7H,6H2,1-5H3;6-7H,3-5H2,1-2H3,(H,9,10);7H,3-6H2,1-2H3;6,11H,5H2,1-4H3,(H,9,10);6-7H,5H2,1-4H3;5-6H,3-4H2,1-2H3,(H,8,9);5-6,9H,3-4H2,1-2H3;6H,3-5H2,1-2H3;2*6H,4-5H2,1-3H3;5H,1-4H3;5H,4H2,1-3H3;4H,1-3H3,(H,6,7);4H,1-3H3.
What are the key properties of 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide?
1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide has a molecular weight of 2732.99 g/mol, XLogP of 23.63, 32 rotatable bonds, 8 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(7-azaspiro[3.5]nonan-7-yl)-2-methylpropan-1-one;1-(azetidin-1-yl)-2-methylpropan-1-one;1-(3,3-dimethylazetidin-1-yl)-2-methylpropan-1-one;2,5-dimethylhexan-3-one;N,2-dimethylpropanamide;1-(3-hydroxyazetidin-1-yl)-2-methylpropan-1-one;1-(4-hydroxy-4-methylpiperidin-1-yl)-2-methylpropan-1-one;N-(2-hydroxy-2-methylpropyl)-2-methylpropanamide;1-(4-hydroxypiperidin-1-yl)-2-methylpropan-1-one;3-methylbutan-2-one;2-methylhexan-3-one;5-methylhexan-3-one;2-methyl-1-[4-methyl-4-(trifluoromethyl)piperidin-1-yl]propan-1-one;2-methyl-1-morpholin-4-ylpropan-1-one;2-methyl-N-(oxetan-3-ylmethyl)propanamide;2-methyl-N-(oxetan-3-yl)propanamide;4-methylpentan-2-one;2,5,5-trimethylhexan-3-one;N,N,2-trimethylpropanamide is sourced from PubChem (CID 163628736), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).